Inhaled Nitric Oxide (iNO) use ( DrugBank: Nitric Oxide )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 294 | Congenital diaphragmatic hernia | 1 |
294. Congenital diaphragmatic hernia
Clinical trials : 15 / Drugs : 36 - (DrugBank : 6) / Drug target genes : 5 - Drug target pathways : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05213676 (ClinicalTrials.gov) | January 1, 2023 | 27/1/2022 | Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The NoNO Trial - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative | Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The NoNO Trial - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative | Congenital Diaphragmatic Hernia | Drug: Inhaled Nitric Oxide (iNO) use;Other: De-implementation of Inhaled Nitric Oxide (iNO) use | The University of Texas Health Science Center, Houston | NULL | Not yet recruiting | N/A | 1 Month | All | 600 | Phase 4 | United States |